Amedeo Smart

Free Medical Literature Service


 

Amedeo

HIV Infection

  Free Subscription

21.05.2018

18 AIDS
4 AIDS Res Hum Retroviruses
1 Am J Epidemiol
2 Antimicrob Agents Chemother
1 Blood
1 Cell
3 Clin Infect Dis
2 HIV Med
23 J Acquir Immune Defic Syndr
3 J Infect Dis
2 J Virol
1 MMWR Morb Mortal Wkly Rep
3 N Engl J Med
1 Pediatr Infect Dis J
14 PLoS One



    AIDS

  1. CICHOWITZ C, Watt MH, Mmbaga BT
    Childbirth experiences of women living with HIV: a neglected event in the prevention of mother-to-child transmission care continuum.
    AIDS. 2018 May 11. doi: 10.1097/QAD.0000000000001860.
    >> Share

  2. GONG S, Tomusange K, Kulkarni V, Adeniji OS, et al
    Anti-HIV IgM protects against mucosal SHIV transmission.
    AIDS. 2018 May 11. doi: 10.1097/QAD.0000000000001857.
    >> Share

  3. WINCKELMANN A, Morcilla V, Shao W, Schleimann MH, et al
    Genetic characterization of the HIV-1 reservoir after Vacc-4x and romidepsin therapy in HIV-1 infected individuals.
    AIDS. 2018 May 11. doi: 10.1097/QAD.0000000000001861.
    >> Share

  4. TSUKAMOTO T
    Transcriptional gene silencing limits CXCR4-associated depletion of bone marrow CD34+ cells in HIV-1 infection.
    AIDS. 2018 May 11. doi: 10.1097/QAD.0000000000001882.
    >> Share

  5. BARNES A, Betts AC, Borton EK, Sanders JM, et al
    Cervical cancer screening among HIV infected women in an urban, U.S. safety-net healthcare system.
    AIDS. 2018 May 11. doi: 10.1097/QAD.0000000000001881.
    >> Share

  6. YANG J, Sharma A, Shi Q, Anastos K, et al
    Improved fracture prediction using different FRAX adjustments in HIV-infected women.
    AIDS. 2018 May 11. doi: 10.1097/QAD.0000000000001864.
    >> Share

  7. MOYO S, Gaseitsiwe S, Powis KM, Pretorius Holme M, et al
    Undisclosed antiretroviral drug use in Botswana: implication for national estimates.
    AIDS. 2018 May 11. doi: 10.1097/QAD.0000000000001862.
    >> Share

  8. ALUISIO AR, Palaniappan A, Farquhar C, Mello MJ, et al
    Integrated HIV-injury programming: An underutilized intersection to engage young adults in HIV care in low- and middle-income countries.
    AIDS. 2018 May 11. doi: 10.1097/QAD.0000000000001876.
    >> Share

  9. DUFFAU P, Ozanne A, Bonnet F, Lazaro E, et al
    Multimorbidity, age-related comorbidities and mortality: association of activation, senescence and inflammation markers in HIV adults.
    AIDS. 2018 May 11. doi: 10.1097/QAD.0000000000001875.
    >> Share

  10. HOORNENBORG E, Coyer L, van Laarhoven A, Achterbergh R, et al
    Change in sexual risk behaviour after six months of pre-exposure prophylaxis use: results from the Amsterdam PrEP demonstration project.
    AIDS. 2018 May 11. doi: 10.1097/QAD.0000000000001874.
    >> Share

  11. DILLON SM, Guo K, Austin GL, Gianella S, et al
    A compartmentalized type I interferon response in the gut during chronic HIV-1 infection is associated with immunopathogenesis.
    AIDS. 2018 May 11. doi: 10.1097/QAD.0000000000001863.
    >> Share

  12. MOLSBERRY SA, Cheng Y, Kingsley L, Jacobson L, et al
    Neuropsychological phenotypes among men with and without HIV disease in the multicenter AIDS cohort study.
    AIDS. 2018 May 11. doi: 10.1097/QAD.0000000000001865.
    >> Share

  13. KILBURN K, Ranganathan M, Stoner MCD, Hughes JP, et al
    Transactional sex and incident HIV infection in a cohort of young women from rural South Africa enrolled in HPTN 068.
    AIDS. 2018 May 11. doi: 10.1097/QAD.0000000000001866.
    >> Share

  14. HEFFRON R, Mugo N, Hong T, Celum C, et al
    Pregnancy outcomes and infant growth among babies with in utero exposure to tenofovir-based pre-exposure prophylaxis for HIV prevention.
    AIDS. 2018 May 11. doi: 10.1097/QAD.0000000000001867.
    >> Share

  15. MONTGOMERY ET, Stadler J, Naidoo S, Katz A, et al
    Reasons for non-adherence to the dapivirine vaginal ring: results of the MTN-032/ AHA study.
    AIDS. 2018 May 11. doi: 10.1097/QAD.0000000000001868.
    >> Share

  16. KONG D, Wang Y, Ji P, Li W, et al
    A defucosylated bispecific multivalent molecule exhibits broad HIV-1 neutralizing activity and enhanced ADCC against reactivated HIV-1 latently infected cells.
    AIDS. 2018 May 11. doi: 10.1097/QAD.0000000000001869.
    >> Share

  17. HARRIS TG, Rabkin M, El-Sadr WM
    Achieving the 4th 90 - Healthy Aging for People Living with HIV.
    AIDS. 2018 May 11. doi: 10.1097/QAD.0000000000001870.
    >> Share

  18. WOODSON E, Goldberg A, Michelo C, Basu D, et al
    HIV transmission in Discordant Couples in Africa in the context of ART availability.
    AIDS. 2018 May 11. doi: 10.1097/QAD.0000000000001871.
    >> Share


    AIDS Res Hum Retroviruses

  19. HIRANSUTHIKUL A, Wongkanya R, Sirivichayakul S, Trachunthong D, et al
    Discordance in drug-resistance mutations between blood plasma and semen or rectal secretion among newly diagnosed HIV-1-infected Thai MSM.
    AIDS Res Hum Retroviruses. 2018 May 14. doi: 10.1089/AID.2018.0029.
    >> Share

  20. DUKHOVLINOVA E, Masharsky A, Vasileva A, Porrello A, et al
    Characterization of the Transmitted Virus in an Ongoing HIV-1 Epidemic Driven by Injecting Drug Use.
    AIDS Res Hum Retroviruses. 2018 May 14. doi: 10.1089/AID.2017.0313.
    >> Share

  21. STEKLER J, Tapia K, Maenza J, Stevens CE, et al
    No time to delay! Fiebig stages and referral in acute HIV infection: Seattle Primary Infection Program Experience.
    AIDS Res Hum Retroviruses. 2018 May 14. doi: 10.1089/AID.2017.0276.
    >> Share

  22. MICHAL JL, Rab S, Patel M, Kyle A, et al
    Incidence of acute kidney injury in patients co-infected with HIV and hepatitis C virus receiving tenofovir disoproxil fumarate and ledipasvir/sofosbuvir in a real-world, urban, Ryan White clinic.
    AIDS Res Hum Retroviruses. 2018 May 16. doi: 10.1089/AID.2017.0271.
    >> Share


    Am J Epidemiol

  23. BRENNAN AT, Bor J, Davies MA, Wandeler G, et al
    Drug Side Effects and Retention on HIV Treatment: a Regression Discontinuity Study of Tenofovir Implementation in South Africa and Zambia.
    Am J Epidemiol. 2018 May 15. pii: 4996076. doi: 10.1093.
    >> Share


    Antimicrob Agents Chemother

  24. BANDA CG, Dzinjalamala F, Mukaka M, Mallewa J, et al
    Pharmacokinetics and safety profile of artesunate-amodiaquine co-administered with antiretroviral therapy in malaria uninfected HIV-positive Malawian adults.
    Antimicrob Agents Chemother. 2018 May 14. pii: AAC.00412.
    >> Share

  25. FOCA E, Calcagno A, Bonito A, Cusato J, et al
    Pharmacokinetic Changes during Pregnancy According to Genetic Variants: A Prospective Study in HIV-infected Patients Receiving Atazanavir/Ritonavir.
    Antimicrob Agents Chemother. 2018 May 14. pii: AAC.00309.
    >> Share


    Blood

  26. GOPAL S, Gross TG
    How I treat Burkitt lymphoma in children, adolescents, and young adults in sub-Saharan Africa.
    Blood. 2018 May 16. pii: blood-2018-04-844472. doi: 10.1182/blood-2018-04-844472
    >> Share


    Cell

  27. HANSEN MMK, Wen WY, Ingerman E, Razooky BS, et al
    A Post-Transcriptional Feedback Mechanism for Noise Suppression and Fate Stabilization.
    Cell. 2018 May 4. pii: S0092-8674(18)30458-6. doi: 10.1016/j.cell.2018.
    >> Share


    Clin Infect Dis

  28. LAMBERT-NICLOT S, Grude M, Meynard JL, Marcelin AG, et al
    Ultrasensitive HIV-1 Viral Load as a Marker of Treatment Choice for Simplification Strategies.
    Clin Infect Dis. 2018 May 15. pii: 4996083. doi: 10.1093.
    >> Share

  29. ELLIOT ER, Wang X, Singh S, Simmons B, et al
    Increased dolutegravir peak concentrations in people living with HIV aged 60 and over and analysis of sleep quality and cognition.
    Clin Infect Dis. 2018 May 16. pii: 4996575. doi: 10.1093.
    >> Share

  30. ZHAO Y, Wu Z, McGoogan JM, Sha Y, et al
    Nationwide cohort study of antiretroviral therapy timing: treatment dropout and virological failure in China, 2011-2015.
    Clin Infect Dis. 2018 May 16. pii: 4996605. doi: 10.1093.
    >> Share


    HIV Med

  31. TRUNFIO M, Vai D, Montrucchio C, Alcantarini C, et al
    Diagnostic accuracy of new and old cognitive screening tools for HIV-associated neurocognitive disorders.
    HIV Med. 2018 May 15. doi: 10.1111/hiv.12622.
    >> Share

  32. GUO F, Cheng X, Hsieh E, Du X, et al
    Prospective plasma efavirenz concentration assessment in Chinese HIV-infected adults enrolled in a large multicentre study.
    HIV Med. 2018 May 15. doi: 10.1111/hiv.12607.
    >> Share


    J Acquir Immune Defic Syndr

  33. SHIAU S, Strehlau R, Shen J, Violari A, et al
    Biomarkers of aging in HIV-infected children on suppressive antiretroviral therapy.
    J Acquir Immune Defic Syndr. 2018 Apr 27. doi: 10.1097/QAI.0000000000001714.
    >> Share

  34. GOLOVATY I, Sharma M, Van Heerden A, van Rooyen H, et al
    Cost of integrating non-communicable disease screening into home-based HIV testing and counseling in South Africa.
    J Acquir Immune Defic Syndr. 2018 May 10. doi: 10.1097/QAI.0000000000001713.
    >> Share

  35. THIRUMURTHY H, Masters SH, Agot K
    Willingness to Pay for HIV Self-Tests Among Women in Kenya: Implications for Subsidy and Pricing Policies.
    J Acquir Immune Defic Syndr. 2018;78:e8-e11.
    >> Share

  36. RANZANI A, Oreni L, Agro M, van den Bogaart L, et al
    Burden of Exposure to Potential Interactions Between Antiretroviral and Non-Antiretroviral Medications in a Population of HIV-Positive Patients Aged 50 Years or Older.
    J Acquir Immune Defic Syndr. 2018;78:193-201.
    >> Share

  37. JUSTMAN JE, Nair GL, Hendrix CW, Piper JM, et al
    Pharmacokinetics and Pharmacodynamics of Tenofovir Reduced-Glycerin 1% Gel in the Rectal and Vaginal Compartments in Women: A Cross-Compartmental Study With Directly Observed Dosing.
    J Acquir Immune Defic Syndr. 2018;78:175-182.
    >> Share

  38. JOTWANI V, Scherzer R, Glidden DV, Mehrotra M, et al
    Pre-exposure Prophylaxis With Tenofovir Disoproxil Fumarate/Emtricitabine and Kidney Tubular Dysfunction in HIV-Uninfected Individuals.
    J Acquir Immune Defic Syndr. 2018;78:169-174.
    >> Share

  39. MAUGHAN-BROWN B, George G, Beckett S, Evans M, et al
    HIV Risk Among Adolescent Girls and Young Women in Age-Disparate Partnerships: Evidence From KwaZulu-Natal, South Africa.
    J Acquir Immune Defic Syndr. 2018;78:155-162.
    >> Share


  40. Neutrophil Activation and Enhanced Release of Granule Products in HIV-TB Immune Reconstitution Inflammatory Syndrome: Erratum.
    J Acquir Immune Defic Syndr. 2018;78:e13.
    >> Share

  41. RADTKE KK, Bacchetti P, Anastos K, Merenstein D, et al
    Use of Nonantiretroviral Medications That May Impact Neurocognition: Patterns and Predictors in a Large, Long-Term HIV Cohort Study.
    J Acquir Immune Defic Syndr. 2018;78:202-208.
    >> Share

  42. BURGER EA, Dyer MA, Sy S, Palefsky JM, et al
    Development and Calibration of a Mathematical Model of Anal Carcinogenesis for High-Risk HIV-Infected Men.
    J Acquir Immune Defic Syndr. 2018 May 9. doi: 10.1097/QAI.0000000000001727.
    >> Share

  43. NOVITSKY V, Gaolathe T, Mmalane M, Moyo S, et al
    Lack of Virological Suppression among Young HIV-Positive Adults in Botswana.
    J Acquir Immune Defic Syndr. 2018 Apr 27. doi: 10.1097/QAI.0000000000001715.
    >> Share

  44. DYER TV, Khan MR, Regan R, Harawa NT, et al
    Differential Patterns of Risk and Vulnerability Suggest the Need for Novel Prevention Strategies for Black Bisexual Men in the HPTN 061 Study.
    J Acquir Immune Defic Syndr. 2018 May 10. doi: 10.1097/QAI.0000000000001716.
    >> Share

  45. MERLIN JS, Long D, Becker WC, Cachay ER, et al
    The Association of Chronic Pain and Long-Term Opioid Therapy with HIV Treatment Outcomes.
    J Acquir Immune Defic Syndr. 2018 May 4. doi: 10.1097/QAI.0000000000001741.
    >> Share

  46. LIGHTFOOT MA, Campbell CK, Moss N, Treves-Kagan S, et al
    Using a Social Network Strategy to Distribute HIV Self-Test Kits to African American and Latino MSM.
    J Acquir Immune Defic Syndr. 2018 May 4. doi: 10.1097/QAI.0000000000001726.
    >> Share

  47. GUITEAU MOISE C, Rivera VR, Hennessey KA, Bellot C, et al
    A Successful Model of Expedited Antiretroviral Therapy for Clinically Stable Patients Living with HIV in Haiti.
    J Acquir Immune Defic Syndr. 2018 Apr 30. doi: 10.1097/QAI.0000000000001725.
    >> Share

  48. CAHN P, Sax PE, Squires K, Molina JM, et al
    Raltegravir 1200 mg once daily vs 400 mg twice daily, with emtricitabine and tenofovir disoproxil fumarate, for previously untreated HIV-1 infection: Week 96 results from ONCEMRK, a randomized, double-blind, non-inferiority trial.
    J Acquir Immune Defic Syndr. 2018 May 3. doi: 10.1097/QAI.0000000000001723.
    >> Share

  49. ACHHRA AC, Sabin C, Ryom L, Hatleberg C, et al
    Body Mass Index and The Risk of Serious Non-Aids Events and All Cause Mortality in Treated Hiv-Positive Individuals: D: A: D Cohort Analysis.
    J Acquir Immune Defic Syndr. 2018 May 3. doi: 10.1097/QAI.0000000000001722.
    >> Share

  50. WAKE RM, Jarvis JN, Harrison TS, Govender NP, et al
    Point of Care Cryptococcal Antigen Screening: Pipetting Finger-Prick Blood Improves Performance of Immuno-Mycologics Lateral Flow Assay.
    J Acquir Immune Defic Syndr. 2018 Apr 30. doi: 10.1097/QAI.0000000000001721.
    >> Share

  51. BALAN IC, Frasca T, Dolezal C, Carballo-Dieguez A, et al
    HIV Risk Reduction by Avoiding Sex with Partners Unwilling to Undergo HIV Testing is Not Coercion.
    J Acquir Immune Defic Syndr. 2018 May 4. doi: 10.1097/QAI.0000000000001740.
    >> Share

  52. VON BRAUN A, Sekaggya-Wiltshire C, Bachmann N, Ssemwanga D, et al
    HIV-1 drug resistance among Ugandan adults attending an urban out-patient clinic.
    J Acquir Immune Defic Syndr. 2018 Apr 27. doi: 10.1097/QAI.0000000000001717.
    >> Share

  53. SHERMAN KE, Rouster SD, Kong LX, Shata TM, et al
    Zika Virus Exposure in an HIV-Infected Cohort in Ghana.
    J Acquir Immune Defic Syndr. 2018 Apr 27. doi: 10.1097/QAI.0000000000001718.
    >> Share

  54. YANIK EL, Hernandez-Ramirez RU, Qin L, Lin H, et al
    Cutaneous Melanoma Risk among People with HIV in the United States and Canada.
    J Acquir Immune Defic Syndr. 2018 Apr 27. doi: 10.1097/QAI.0000000000001719.
    >> Share

  55. LOPEZ-VARELA E, Fuente-Soro L, Augusto OJ, Sacoor C, et al
    The Continuum of HIV Care in Rural Mozambique: The Implications of HIV Testing Modality on Linkage and Retention.
    J Acquir Immune Defic Syndr. 2018 Apr 27. doi: 10.1097/QAI.0000000000001720.
    >> Share


    J Infect Dis

  56. TWISK DE, van der Sande MAB, van Eeden A, Heideman DAM, et al
    Detection of Incident Anal High-Risk Hpv-Dna in Msm: Incidence or Reactivation?
    J Infect Dis. 2018 May 16. pii: 4996623. doi: 10.1093.
    >> Share

  57. KOAY WLA, Lindsey JC, Uprety P, Bwakura-Dangarembizi M, et al
    Intestinal Integrity Biomarkers in Early Antiretroviral-Treated Perinatally HIV-1-Infected Infants.
    J Infect Dis. 2018 May 12. pii: 4995578. doi: 10.1093.
    >> Share

  58. REICHLER MR, Khan A, Sterling TR, Zhao H, et al
    Risk and Timing of Tuberculosis Among Close Contacts of Persons with Infectious Tuberculosis.
    J Infect Dis. 2018 May 15. pii: 4996045. doi: 10.1093.
    >> Share


    J Virol

  59. CAREY BD, Ammosova T, Pinkham C, Lin X, et al
    Protein Phosphatase 1alpha Interacts with Venezuelan Equine Encephalitis Virus Capsid Protein and Regulates Viral Replication through Modulation of Capsid Phosphorylation.
    J Virol. 2018 May 16. pii: JVI.02068-17. doi: 10.1128/JVI.02068.
    >> Share

  60. KUMAR S, Morrison JH, Dingli D, Poeschla E, et al
    HIV-1 activation of innate immunity depends strongly on the intracellular level of TREX1 and sensing of incomplete reverse transcription products.
    J Virol. 2018 May 16. pii: JVI.00001-18. doi: 10.1128/JVI.00001.
    >> Share


    MMWR Morb Mortal Wkly Rep

  61. BURRAGE A, Patel M, Mirkovic K, Dziuban E, et al
    Trends in Antiretroviral Therapy Eligibility and Coverage Among Children Aged <15 Years with HIV Infection - 20 PEPFAR-Supported Sub-Saharan African Countries, 2012-2016.
    MMWR Morb Mortal Wkly Rep. 2018;67:552-555.
    >> Share


    N Engl J Med

  62. GOMEZ CA, Banaei N
    Trypanosoma cruzi Reactivation in the Brain.
    N Engl J Med. 2018;378:1824.
    >> Share

  63. ZUGER A
    Moving On.
    N Engl J Med. 2018;378:1763-1765.
    >> Share

  64. JUSTMAN JE, Mugurungi O, El-Sadr WM
    HIV Population Surveys - Bringing Precision to the Global Response.
    N Engl J Med. 2018;378:1859-1861.
    >> Share


    Pediatr Infect Dis J

  65. HUIBERS MHW, Moons P, Maseko N, Gushu MB, et al
    Multiplex Real-Time PCR Detection of Intestinal Protozoa in HIV-Infected Children in Malawi, Enterocytozoon Bieneusi is Common and Associated with Gastrointestinal Complaints and May Delay BMI (Nutritional Status) Recovery.
    Pediatr Infect Dis J. 2018 May 14. doi: 10.1097/INF.0000000000001924.
    >> Share


    PLoS One

  66. JOSEPH DAVEY D, Farley E, Towriss C, Gomba Y, et al
    Risk perception and sex behaviour in pregnancy and breastfeeding in high HIV prevalence settings: Programmatic implications for PrEP delivery.
    PLoS One. 2018;13:e0197143.
    >> Share

  67. LILIAN RR, Railton J, Schaftenaar E, Mabitsi M, et al
    Strengthening primary eye care in South Africa: An assessment of services and prospective evaluation of a health systems support package.
    PLoS One. 2018;13:e0197432.
    >> Share

  68. DUTTA D, Johnson S, Dalal A, Deymier MJ, et al
    High throughput generation and characterization of replication-competent clade C transmitter-founder simian human immunodeficiency viruses.
    PLoS One. 2018;13:e0196942.
    >> Share

  69. CHANG RC, Hail-Jares K, Zheng H, He N, et al
    Mitigating circumstances: A model-based analysis of associations between risk environment and infrequent condom use among Chinese street-based sex workers.
    PLoS One. 2018;13:e0195982.
    >> Share

  70. MARTIN-CANAVATE R, Sonego M, Sagrado MJ, Escobar G, et al
    Dietary patterns and nutritional status of HIV-infected children and adolescents in El Salvador: A cross-sectional study.
    PLoS One. 2018;13:e0196380.
    >> Share

  71. MCCREESH N, Andrianakis I, Nsubuga RN, Strong M, et al
    Choice of time horizon critical in estimating costs and effects of changes to HIV programmes.
    PLoS One. 2018;13:e0196480.
    >> Share

  72. YAYLALI E, Farnham PG, Cohen S, Purcell DW, et al
    Optimal allocation of HIV prevention funds for state health departments.
    PLoS One. 2018;13:e0197421.
    >> Share

  73. PATHMANATHAN I, Pasipamire M, Pals S, Dokubo EK, et al
    High uptake of antiretroviral therapy among HIV-positive TB patients receiving co-located services in Swaziland.
    PLoS One. 2018;13:e0196831.
    >> Share

  74. FELLOWS IE, Morris M, Birnbaum JK, Dombrowski JC, et al
    Correction: A New Method for Estimating the Number of Undiagnosed HIV Infected Based on HIV Testing History, with an Application to Men Who Have Sex with Men in Seattle/King County, WA.
    PLoS One. 2018;13:e0197707.
    >> Share

  75. SUTTON MY, Zhou W, Frazier EL
    Unplanned pregnancies and contraceptive use among HIV- positive women in care.
    PLoS One. 2018;13:e0197216.
    >> Share

  76. BORTHWICK NJ, Lane T, Moyo N, Crook A, et al
    Randomized phase I trial HIV-CORE 003: Depletion of serum amyloid P component and immunogenicity of DNA vaccination against HIV-1.
    PLoS One. 2018;13:e0197299.
    >> Share

  77. YOURKAVITCH J, Hassmiller Lich K, Flax VL, Okello ES, et al
    Interactions among poverty, gender, and health systems affect women's participation in services to prevent HIV transmission from mother to child: A causal loop analysis.
    PLoS One. 2018;13:e0197239.
    >> Share

  78. EJIGU BA, Wencheko E, Berhane K
    Spatial pattern and determinants of anaemia in Ethiopia.
    PLoS One. 2018;13:e0197171.
    >> Share

  79. GUTHRIE KM, Rosen RK, Vargas SE, Getz ML, et al
    User evaluations offer promise for pod-intravaginal ring as a drug delivery platform: A mixed methods study of acceptability and use experiences.
    PLoS One. 2018;13:e0197269.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016